Treatment with the IDO inhibitor INCB024360 increased lysis of human tumor cell targets by peptide-specific CTL

Documenti analoghi

• The IDO1 selective inhibitor epacadostat enhances dendritic cell immunogenicity and lytic ability of tumor antigen-specific T cells
  di: Jochems, Caroline, et al.
  Pubblicazione: (2016)
• Combination Chemotherapy and Radiation of Human Squamous Cell Carcinoma of the Head and Neck Augments CTL-Mediated Lysis
  di: Gelbard, Alexander, et al.
  Pubblicazione: (2006)
• Inhibitors of histone deacetylase 1 reverse the immune evasion phenotype to enhance T-cell mediated lysis of prostate and breast carcinoma cells
  di: Gameiro, Sofia R., et al.
  Pubblicazione: (2016)
• ADCC employing an NK cell line (haNK) expressing the high affinity CD16 allele with avelumab, an anti-PD-L1 antibody
  di: Jochems, Caroline, et al.
  Pubblicazione: (2017)
• Induction of Higher Avidity Human CTL by Vector-Mediated Enhanced Costimulation of Antigen-Presenting Cells
  di: Yang, Sixun, et al.
  Pubblicazione: (2005)